AdviseClinical’s Sequence clinical research platform is a comprehensive and user friendly system providing fast clinical study implementation capabilities. Our pricing structure is conducive to all clinical phases including Phase I and many-site, long-term, late phase studies. Sequence is licensed in a Software as a Service (SaaS) model which means you only pay our very reasonable license fee while your study is active with no large upfront fees. We implement our studies turnkey as an extension of your clinical team with the product carrying your brand and logos. All Sequence Platform modules run seamlessly integrated or standalone and are 21 CFR Part 11 compliant and fully validated.